Experiences with
Interferon1,152 public posts
ASCO presentations on melanoma research this week
ASC0 released adjuvant clinical trial from 2015-17 cohort comparing Keytruda vs Yervoy vs high dose interferon for Stage 3A-4 melanoma patients. Adjuvant Anti-PD-1 Misses on Overall Survival (OS) in High-Risk Melanoma, but pembrolizumab topped active controls for relapse-free survival.
Want to take advantage of all our features? Just log in!
or